Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity.

Zhao D, Alizadeh D, Zhang L, Liu W, Farrukh O, Manuel E, Diamond DJ, Badie B.

Clin Cancer Res. 2011 Feb 15;17(4):771-82. doi: 10.1158/1078-0432.CCR-10-2444. Epub 2010 Nov 18.

PMID:
21088258
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy.

Alizadeh D, Zhang L, Brown CE, Farrukh O, Jensen MC, Badie B.

Clin Cancer Res. 2010 Jul 1;16(13):3399-408. doi: 10.1158/1078-0432.CCR-09-3087. Epub 2010 Jun 22.

PMID:
20570924
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice.

Fan H, Zhang I, Chen X, Zhang L, Wang H, Da Fonseca A, Manuel ER, Diamond DJ, Raubitschek A, Badie B.

Clin Cancer Res. 2012 Oct 15;18(20):5628-38. doi: 10.1158/1078-0432.CCR-12-1911. Epub 2012 Aug 17.

PMID:
22904105
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

TLR ligands in the local treatment of established intracerebral murine gliomas.

Grauer OM, Molling JW, Bennink E, Toonen LW, Sutmuller RP, Nierkens S, Adema GJ.

J Immunol. 2008 Nov 15;181(10):6720-9.

PMID:
18981089
[PubMed - indexed for MEDLINE]
Free Article
5.

Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.

El Andaloussi A, Sonabend AM, Han Y, Lesniak MS.

Glia. 2006 Nov 1;54(6):526-35.

PMID:
16906541
[PubMed - indexed for MEDLINE]
6.

Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model.

VanHandel M, Alizadeh D, Zhang L, Kateb B, Bronikowski M, Manohara H, Badie B.

J Neuroimmunol. 2009 Mar 31;208(1-2):3-9. doi: 10.1016/j.jneuroim.2008.12.006. Epub 2009 Jan 31.

PMID:
19181390
[PubMed - indexed for MEDLINE]
7.

Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.

Carpentier AF, Xie J, Mokhtari K, Delattre JY.

Clin Cancer Res. 2000 Jun;6(6):2469-73.

PMID:
10873101
[PubMed - indexed for MEDLINE]
Free Article
8.

CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.

Roda JM, Parihar R, Carson WE 3rd.

J Immunol. 2005 Aug 1;175(3):1619-27.

PMID:
16034101
[PubMed - indexed for MEDLINE]
Free Article
9.

S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.

Wang H, Zhang L, Zhang IY, Chen X, Da Fonseca A, Wu S, Ren H, Badie S, Sadeghi S, Ouyang M, Warden CD, Badie B.

Clin Cancer Res. 2013 Jul 15;19(14):3764-75. doi: 10.1158/1078-0432.CCR-12-3725. Epub 2013 May 29.

PMID:
23719262
[PubMed - indexed for MEDLINE]
10.

Implication of macrophages in tumor rejection induced by CpG-oligodeoxynucleotides without antigen.

Auf G, Carpentier AF, Chen L, Le Clanche C, Delattre JY.

Clin Cancer Res. 2001 Nov;7(11):3540-3.

PMID:
11705874
[PubMed - indexed for MEDLINE]
Free Article
11.

Treg depletion followed by intracerebral CpG-ODN injection induce brain tumor rejection.

Jarry U, Donnou S, Vincent M, Jeannin P, Pineau L, Fremaux I, Delneste Y, Couez D.

J Neuroimmunol. 2014 Feb 15;267(1-2):35-42. doi: 10.1016/j.jneuroim.2013.12.005. Epub 2013 Dec 12.

PMID:
24369298
[PubMed - indexed for MEDLINE]
12.

Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.

Ginzkey C, Eicker SO, Marget M, Krause J, Brecht S, Westphal M, Hugo HH, Mehdorn HM, Steinmann J, Hamel W.

Cancer Immunol Immunother. 2010 Apr;59(4):541-51. doi: 10.1007/s00262-009-0771-y. Epub 2009 Oct 2.

PMID:
19798500
[PubMed - indexed for MEDLINE]
13.

Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma.

Ursu R, Carpentier AF.

Adv Exp Med Biol. 2012;746:95-108. doi: 10.1007/978-1-4614-3146-6_8. Review.

PMID:
22639162
[PubMed - indexed for MEDLINE]
14.

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.

Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.

J Immunother. 2007 Nov-Dec;30(8):789-97.

PMID:
18049330
[PubMed - indexed for MEDLINE]
15.

Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment.

Ben Abdelwahed R, Cosette J, Donnou S, Crozet L, Ouakrim H, Fridman WH, Sautès-Fridman C, Mahjoub A, Fisson S.

J Exp Clin Cancer Res. 2013 Apr 5;32:18. doi: 10.1186/1756-9966-32-18.

PMID:
23561041
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.

Fujita M, Zhu X, Sasaki K, Ueda R, Low KL, Pollack IF, Okada H.

J Immunol. 2008 Feb 15;180(4):2089-98.

PMID:
18250414
[PubMed - indexed for MEDLINE]
Free Article
17.

A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment.

Cantini G, Pisati F, Mastropietro A, Frattini V, Iwakura Y, Finocchiaro G, Pellegatta S.

Cancer Immunol Immunother. 2011 Dec;60(12):1739-50. doi: 10.1007/s00262-011-1069-4. Epub 2011 Jul 21.

PMID:
21779877
[PubMed - indexed for MEDLINE]
18.

Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.

Merlo A, Calcaterra C, Mènard S, Balsari A.

J Leukoc Biol. 2007 Sep;82(3):509-18. Epub 2007 Jun 22.

PMID:
17586660
[PubMed - indexed for MEDLINE]
Free Article
19.

Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.

Hiraoka K, Yamamoto S, Otsuru S, Nakai S, Tamai K, Morishita R, Ogihara T, Kaneda Y.

J Immunol. 2004 Oct 1;173(7):4297-307.

PMID:
15383558
[PubMed - indexed for MEDLINE]
Free Article
20.

Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model.

Hamzah J, Altin JG, Herringson T, Parish CR, Hämmerling GJ, O'Donoghue H, Ganss R.

J Immunol. 2009 Jul 15;183(2):1091-8. doi: 10.4049/jimmunol.0900736. Epub 2009 Jun 26.

PMID:
19561111
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk